20170628182643b6d1090b2-8235-4860-8281-743f52e15ed4

Samsung BioLogics’ shares down $6bn after accounting furore

May 2, 2018
Research and Development, Sales and Marketing Samsung BioLogics, Samsung Bioepis, biotech, drugs, pharma, pharmaceutical, south korea

Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of …

aaron_traywick

Startup CEO who injected untested herpes cure during live stream found dead

May 2, 2018
Research and Development Aaron Traywick, Ascendance Biomedical, HIV, herpes, pharma

Aaron Traywick, the 28-year-old CEO of biotech startup Ascendance Biomedical who made headlines when he injected himself with an untested …

novartis_window

Novartis becomes first to gain second CAR T indication

May 2, 2018
Research and Development, Sales and Marketing Gilead, Kymriah, Novartis, Yescarta, biotech, drugs, pharma, pharmaceutical

Novartis has announced that its CAR T treatment, Kymriah, has successfully been given a second indication for the treatment of …

praluentalirocumab_1211441

Sanofi/Regeneron forced to slash price in wake of slow sales

May 1, 2018
Research and Development, Sales and Marketing Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical, praluent

Sanofi and Regeneron were touted as having a sure-fire blockbuster on their hands when they first brought Praluent to market …

jon_neal-1_0

Takeda announces new UK MD, ahead of Shire transformation

May 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Takeda, appointment, pharma

“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …

image_credit_porton_biopharma

Porton Biopharma opens new leukaemia drug production facility

May 1, 2018
Manufacturing and Production Porton Biopharma, leukaemia, pharma

Porton Biopharma Limited (PBL) has officially opened the doors of its new fermentation facility. John Glen, MP for Salisbury and …

ovariancancer

Ovarian cancer rates set to rise by 55%

May 1, 2018
Manufacturing and Production, Medical Communications biotech, drugs, ovarian cancer, pharma, pharmaceutical

Ahead of World Ovarian Cancer Day on 8 May, new figures have been released suggesting that rates of this type …

credit_rich_s

United Therapeutics to acquire SteadyMed for $216 million

May 1, 2018
Manufacturing and Production, Sales and Marketing SteadyMed, UnitedTherapeutics, acquisition, pharma

United Therapeutics is set to acquire speciality pharma firm SteadyMed after it emerged that the pair had signed a definitive …

eye1

Novartis reveals more data for Eylea rival

May 1, 2018
Manufacturing and Production, Research and Development biotech, drugs, pharma, pharmaceutical

Building on the back of strong data released at the end of last year, Novartis has released further positive Phase …

gandhi

Lilly hires new leader of immuno-oncology

May 1, 2018
Manufacturing and Production, Medical Communications Eli Lilly, biotech, drugs, immunoconlogy, immunotherapy, pharma, pharmaceutical

Immuno-oncology has become a huge area of the oncology market, led by the wave of PD-1/L1 drugs that are reaping …

medopad

Connecting patients to doctors

April 30, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dan Vahdat, CEO and Co-founder of Medopad, discusses the rapid expansion of the app he helped develop, as its mobile …

EMA’s CHMP backs Roche’s Perjeta combo in HER2-positive breast cancer

April 30, 2018
Sales and Marketing Cancer, Herceptin, Perjeta, Roche, breast cancer, pharma

Roche’s Perjeta has edged one step closer to approval as a combo therapy after the EMA’s Committee for Medicinal Products …

piggy-2889042_960_720

Alzheon shies away from $81m IPO

April 30, 2018
Sales and Marketing Alzheon, biotech, drugs, pharma, pharmaceutical

Alzheon, a tiny biotech based in the Boston area, had initially launched its roadshow for an IPO potentially worth up …

allergan

Allergan unveils second bout of Phase 3 success in migraine

April 30, 2018
Research and Development, Sales and Marketing Allergan, migraine, pharma, ubrogepant

Allergan has revealed new data from the second of two Phase 3 studies into the efficacy of its calcitonin gene-related …

canada_and_usa_flag

US applies pressure on Canada to stem cross-border generics flow

April 30, 2018
Sales and Marketing Canada, IP, US, biotech, drugs, pharma, pharmaceutical

The US has upped the ante against Canada to secure stronger border checks for pharmaceutical goods by adding the country …

18538_700x200

Navigating CMC Requirements during drug development and post-approval

April 30, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dia

This training will offer you the overview of the existing regulatory aspects of the CMC, and will also give you …

hans-bishop_2x

Juno CEO and Co-founder steps down in wake of Celgene acquisition

April 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Juno, appointment, pharma

Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …

john_reed

Sanofi makes ex-Roche scientist new R&D chief

April 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Sanofi, appointment, pharma

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …

lilly_entrance_web

Eli Lilly partners with Chinese institution to advance the nation’s diabetes and CVD care

April 27, 2018
Medical Communications, Research and Development China, Eli Lilly, cardiovascular disorders, cvd, diabetes, pharma, type 2 diabetes

EIi Lilly has announced plans to partner up with China’s National Center for Cardiovascular Diseases (NCCD), the nation’s institution responsible …

The Gateway to Local Adoption Series

Latest content